| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.62▼ | 3.63▼ | 3.65▼ | 3.64▼ | 3.60▲ |
| MA10 | 3.63▼ | 3.65▼ | 3.66▼ | 3.51▲ | 3.87▼ |
| MA20 | 3.63▼ | 3.65▼ | 3.66▼ | 3.51▲ | 4.72▼ |
| MA50 | 3.65▼ | 3.65▼ | 3.58▲ | 3.96▼ | 5.99▼ |
| MA100 | 3.66▼ | 3.54▲ | 3.46▲ | 4.89▼ | 6.72▼ |
| MA200 | 3.65▼ | 3.45▲ | 3.64▼ | 5.96▼ | 6.20▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.008▼ | -0.013▼ | 0.070▲ | -0.069▼ |
| RSI | 32.793▼ | 41.162▼ | 44.563▼ | 47.259▼ | 25.730▼ |
| STOCH | 12.698▼ | 34.205 | 40.000 | 89.483▲ | 16.477▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -18.440▲ | -76.386▼ |
| CCI | -153.768▼ | -188.692▼ | -232.030▼ | 79.056 | -74.251 |
|
Saturday, May 09, 2026 02:03 AM
MiMedx (MDXG) stock is downgraded to Hold after the 2026 revenue guide cut and Q1 decline. Read here for a detailed investment analysis.
|
|
Friday, May 08, 2026 05:59 AM
Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company's Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx ...
|
|
Friday, May 08, 2026 05:09 AM
Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company’s PortfolioG4Derm Plus Added to Premier and Vizient GPO ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 3.72 | 3.72 | 3.60 | 3.60 | 1,309,487 |
| 07/05/26 | 3.66 | 3.715 | 3.62 | 3.69 | 1,529,570 |
| 06/05/26 | 3.65 | 3.69 | 3.60 | 3.66 | 1,570,547 |
| 05/05/26 | 3.59 | 3.73 | 3.59 | 3.64 | 1,900,707 |
| 04/05/26 | 3.61 | 3.67 | 3.565 | 3.61 | 2,182,685 |
| 01/05/26 | 3.42 | 3.70 | 3.385 | 3.68 | 2,594,881 |
| 30/04/26 | 3.05 | 3.39 | 3.05 | 3.36 | 3,265,154 |
| 29/04/26 | 3.35 | 3.40 | 3.025 | 3.085 | 3,362,278 |
| 28/04/26 | 3.35 | 3.41 | 3.315 | 3.40 | 1,452,810 |
| 27/04/26 | 3.43 | 3.48 | 3.33 | 3.34 | 1,100,184 |
|
|
||||
|
|
||||
|
|